Cancer clinical trials in the region Bretagne
204 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Breast cancer
#NCT05386108
#2024-512878-98-00
HER2 Negative
HR Positive
Metastatic
1
2
3 or more
Chemotherapy
Targeted therapy
Hormone therapy
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Stemline Therapeutics, Inc.
Phase 2
Lung cancer
#NCT06656598
#2024-517316-29-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
None
Systemic Treatment-Naive
ALK
EGFR
ROS-1
Immunotherapy
Chemotherapy
CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Prostate cancer
#NCT07047118
#2024-520155-24-00
Adenocarcinoma
Metastatic Castration-resistant
PSMA PET Positive
1
2
3 or more
Hormone therapy
Systemic Treatment-Naive
Internal Vectorised Radiotherapy (IVR)
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Novartis
Phase 2
Lung cancer
#NCT06465329
#2023-509806-31-00
NSCLC (Non-Small Cell Lung Cancer)
Localized
None
Systemic Treatment-Naive
ALK
EGFR
Radiotherapy
CHU de Rennes - Hôpital Pontchaillou (Rennes)
Regeneron Pharmaceuticals
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
MET
None
1
Targeted therapy
ALK
BRAF
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Apollomics
Phase 2
Liver and bile duct cancer
#NCT06551272
#2023-508201-25-00
Hepatocellular carcinoma
Locally Advanced
Metastatic
Unhealthy
A
1
Immunotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Eugene Marquis (Rennes)
Centre Eugène Marquis
Phase 2
Pancreas cancer
#NCT05732831
#2022-502645-99-00
Adenocarcinoma
Locally Advanced
Metastatic
MTAP
1
2
3 or more
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Tango Therapeutics
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
#NCT05732831
#2022-502645-99-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
MTAP
1
2
3 or more
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Tango Therapeutics
Phase 2
Breast cancer
#NCT05296746
#2023-508827-10-00
HER2 Negative
HR Positive
Localized
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Hospitalier Bretagne Atlantique (Vannes), Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire), Centre Hospitalier de Cornouaille (Quimper)
Novartis
Phase 2
Breast cancer
#NCT05297617
#2024-514480-26-00
HER2 Negative
HR Positive
Localized
None
Surgery
Hormone therapy
Chemotherapy
Centre Hospitalier de Saint-Malo (Saint-Malo), Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire), Centre Hospitalier de Cornouaille (Quimper), CHP Brest - Pasteur Vivalto Santé (Brest)
UNICANCER